Drug intelligence / Profile preview

Gushuling

Development stage: Unknown
Administration: Oral

Overview

Gushuling (GSL) is a traditional Chinese medicine (TCM) hospital preparation that has been widely used in clinical practice, particularly for the treatment of osteoporosis. It is composed of multiple herbal ingredients, though the exact formulation may vary by institution. The mechanism of action is believed to involve modulation of bone metabolism and improvement in bone density, but specific molecular targets or pathways have not been fully elucidated. Its use is primarily based on TCM principles and empirical evidence from clinical practice in China[9].

Brand names: Gushuling
Other names: GSL

Beyond the preview

Go deeper on Gushuling.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gushuling.

Explore the full profile